Hanmi, Amneal anticipate FDA nod for generic heartburn med

06/6/2013 | Drug Store News

Hanmi Pharmaceutical, a South Korean drugmaker, and partner Amneal Pharmaceuticals are expecting the FDA to approve Hanmi's esomeprazole-strontium as treatment for heartburn. The drug is a generic version of AstraZeneca's Nexium.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ